|
| Exchange Disseminated Time 15/05/2017 12:29:44 | Divis Laboratories Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on May 26, 2017, inter alia, to consider and approve standalone and consolidated audited financial results for the year ended March 31, 2017 and to recommend dividend, if any, on Equity Shares for the financial year 2016-17.
Further, the Trading Window for dealing in securities of the Company shall remain closed for insiders of the Company from May 19, 2017 to May 28, 2017 (both days inclusive) as per the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015. |
|
|